These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12757376)

  • 1. A concise method for the preparation of peptide and arginine-rich peptide-conjugated antisense oligonucleotide.
    Chen CP; Zhang LR; Peng YF; Wang XB; Wang SQ; Zhang LH
    Bioconjug Chem; 2003; 14(3):532-8. PubMed ID: 12757376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides.
    Moulton HM; Nelson MH; Hatlevig SA; Reddy MT; Iversen PL
    Bioconjug Chem; 2004; 15(2):290-9. PubMed ID: 15025524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of phosphorothioate oligonucleotide-peptide conjugates by solid phase fragment condensation.
    Diala I; Osada A; Maruoka S; Imanisi T; Murao S; Ato T; Ohba H; Fujii M
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6576-8. PubMed ID: 17942304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stepwise synthesis of oligonucleotide-peptide conjugates containing guanidinium and lipophilic groups in their 3'-termini.
    Grijalvo S; Terrazas M; Aviñó A; Eritja R
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2144-7. PubMed ID: 20206515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arginine-rich peptide conjugation to morpholino oligomers: effects on antisense activity and specificity.
    Nelson MH; Stein DA; Kroeker AD; Hatlevig SA; Iversen PL; Moulton HM
    Bioconjug Chem; 2005; 16(4):959-66. PubMed ID: 16029037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-(2-aminooxyethoxy)-2-(ethylureido)quinoline-oligonucleotide conjugates: synthesis, binding interactions, and derivatization with peptides.
    Hamma T; Miller PS
    Bioconjug Chem; 2003; 14(2):320-30. PubMed ID: 12643742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The solution synthesis of antisense oligonucleotide-peptide conjugates directly linked via phosphoramide bond by using a fragment coupling approach.
    Sumbatyan NV; Mandrugin VA; Deroussent A; Bertrand JR; Majer Z; Malvy C; Korshunova GA; Hollosi M; Gottikh MB
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(12):1911-27. PubMed ID: 15628748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Native chemical ligation in the synthesis of internally modified oligonucleotide-peptide conjugates.
    Diezmann F; Eberhard H; Seitz O
    Biopolymers; 2010; 94(4):397-404. PubMed ID: 20593471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligonucleotide-peptide conjugates as potential antisense agents.
    Zubin EM; Romanova EA; Volkov EM; Tashlitsky VN; Korshunova GA; Shabarova ZA; Oretskaya TS
    FEBS Lett; 1999 Jul; 456(1):59-62. PubMed ID: 10452530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide-assisted delivery of steric-blocking antisense oligomers.
    Moulton HM; Moulton JD
    Curr Opin Mol Ther; 2003 Apr; 5(2):123-32. PubMed ID: 12772501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
    Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
    Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precisely controlled intracellular delivery of DNA-peptide conjugates.
    Kubo T; Kanno K; Rumiana B; Ohba H; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2004; (48):99-100. PubMed ID: 17150497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of antisense oligonucleotide-peptide conjugate targeting to GLUT-1 in HepG-2 and MCF-7 Cells.
    Chen CP; Li XX; Zhang LR; Min JM; Chan JY; Fung KP; Wang SQ; Zhang LH
    Bioconjug Chem; 2002; 13(3):525-9. PubMed ID: 12009942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-oligonucleotide conjugates for the delivery of antisense and siRNA.
    Juliano RL
    Curr Opin Mol Ther; 2005 Apr; 7(2):132-6. PubMed ID: 15844620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of intracellular delivery of oligonucleotides by signal peptides and genetic expression in human cells.
    Kubo T; Kanno K; Ohba H; Rumiana B; Fujii M
    Nucleic Acids Symp Ser (Oxf); 2004; (48):303-4. PubMed ID: 17150599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arginine-rich cell-penetrating peptides with uncharged antisense oligomers.
    Moulton HM; Moulton JD
    Drug Discov Today; 2004 Oct; 9(20):870. PubMed ID: 15475318
    [No Abstract]   [Full Text] [Related]  

  • 17. Oligonucleotides conjugated to short lysine chains.
    Winkler J; Urban E; Noe CR
    Bioconjug Chem; 2005; 16(4):1038-44. PubMed ID: 16029048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of oligonucleotide-peptide conjugates for biomedical and technological applications.
    Aviñó A; Grijalvo S; Pérez-Rentero S; Garibotti A; Terrazas M; Eritja R
    Methods Mol Biol; 2011; 751():223-38. PubMed ID: 21674334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled intracellular localization and enhanced antisense effect of oligonucleotides by chemical conjugation.
    Kubo T; Zhelev Z; Bakalova R; Ohba H; Doi K; Fujii M
    Org Biomol Chem; 2005 Sep; 3(18):3257-9. PubMed ID: 16132084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
    Tünnemann G; Ter-Avetisyan G; Martin RM; Stöckl M; Herrmann A; Cardoso MC
    J Pept Sci; 2008 Apr; 14(4):469-76. PubMed ID: 18069724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.